NO922521L - Piperidinyletanolderivater med terapeutisk virkning - Google Patents

Piperidinyletanolderivater med terapeutisk virkning

Info

Publication number
NO922521L
NO922521L NO92922521A NO922521A NO922521L NO 922521 L NO922521 L NO 922521L NO 92922521 A NO92922521 A NO 92922521A NO 922521 A NO922521 A NO 922521A NO 922521 L NO922521 L NO 922521L
Authority
NO
Norway
Prior art keywords
group
piperidinyletanode
derivatives
therapeutic effect
hydrogen
Prior art date
Application number
NO92922521A
Other languages
English (en)
Other versions
NO922521D0 (no
Inventor
Jonathan Frost
Patrick Lardenois
Maria-Carmen Renones
Corinne Rousselle
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9107934A external-priority patent/FR2678265B1/fr
Priority claimed from FR9107936A external-priority patent/FR2678270B1/fr
Priority claimed from FR9204507A external-priority patent/FR2689891B3/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO922521D0 publication Critical patent/NO922521D0/no
Publication of NO922521L publication Critical patent/NO922521L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Forbindelser i form av optisk rene isomerer eller blanding av to enantiomerer med generell formel (I). hvori er et hydrogen- eller halogenatom eller en metyl-gruppe, Rer en eller to substituenter valgt blant hydrogen-og halogenatomene og gruppen (C_)alkyl, hydroksy, (C_)alkoksy, trifluormetyl, acetylamino og metylsulfonylamino, og X er enten en CHgruppe og Y er en CH2. (C)eller CO gruppe, eller X er en CO gruppe og Y er en CHgruppe.En fremgangsmåte for deres fremstilling er beskrevet.Forbindelsene har terapeutisk anvendelse.
NO92922521A 1991-06-27 1992-06-26 Piperidinyletanolderivater med terapeutisk virkning NO922521L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9107934A FR2678265B1 (fr) 1991-06-27 1991-06-27 Derives de 4-(2-phenylethyl)piperidine, leur preparation et leur application en therapeutique.
FR9107936A FR2678270B1 (fr) 1991-06-27 1991-06-27 Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
FR9204507A FR2689891B3 (fr) 1992-04-13 1992-04-13 Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
NO922521D0 NO922521D0 (no) 1992-06-26
NO922521L true NO922521L (no) 1992-12-28

Family

ID=27252473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922521A NO922521L (no) 1991-06-27 1992-06-26 Piperidinyletanolderivater med terapeutisk virkning

Country Status (14)

Country Link
EP (1) EP0524846A1 (no)
JP (1) JPH05186460A (no)
KR (1) KR930000505A (no)
CN (1) CN1069491A (no)
AU (1) AU644296B2 (no)
CA (1) CA2072520A1 (no)
CZ (1) CZ199992A3 (no)
FI (1) FI922979A (no)
HU (1) HUT61743A (no)
IE (1) IE922090A1 (no)
IL (1) IL102334A0 (no)
MX (1) MX9203452A (no)
NO (1) NO922521L (no)
NZ (1) NZ243337A (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001403A1 (en) * 1992-07-08 1994-01-20 Shell Internationale Research Maatschappij B.V. Piperidine derivatives
NZ255074A (en) * 1992-10-30 1996-10-28 Pfizer 6-[2-(4-hydroxy-4-(4-substituted phenyl)piperidino)-1-hydroxypropyl]-3,4-dihydro-2(1h)-quinolones
FR2727864B1 (fr) * 1994-12-12 1997-04-04 Synthelabo Utilisation des ligands des sites de liaison peripherique pour les benzodiazepines pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
FR2778564B1 (fr) * 1998-05-13 2001-07-13 Sanofi Sa Utilisation de composes reduisant l'apoptose
WO1999058117A1 (fr) * 1998-05-13 1999-11-18 Sanofi-Synthelabo Utilisation de composes reduisant l'apoptose
AU2185100A (en) 1998-12-18 2000-07-12 Scios Inc. Agonists and antagonists of peripheral-type benzodiazepine receptors
US20070185168A1 (en) * 2004-04-07 2007-08-09 Takai Haruki S Piperidine derivatives
CN103896835A (zh) * 2014-04-20 2014-07-02 武汉珈瑜科技有限公司 喹啉酮类衍生物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1030415A (zh) * 1987-02-20 1989-01-18 山之内制药株式会社 饱和的杂环碳酰胺衍生物和它的制备方法
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JPH03130263A (ja) * 1989-07-19 1991-06-04 Eisai Co Ltd 光学活性ナフチルエタノール誘導体
FR2668149B1 (fr) * 1990-10-18 1994-09-23 Synthelabo Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique.

Also Published As

Publication number Publication date
EP0524846A1 (fr) 1993-01-27
FI922979A0 (fi) 1992-06-26
FI922979A (fi) 1992-12-28
HU9202138D0 (en) 1992-10-28
CZ199992A3 (en) 1993-01-13
HUT61743A (en) 1993-03-01
AU1858992A (en) 1993-01-07
JPH05186460A (ja) 1993-07-27
NO922521D0 (no) 1992-06-26
CN1069491A (zh) 1993-03-03
AU644296B2 (en) 1993-12-02
MX9203452A (es) 1994-01-31
IE922090A1 (en) 1992-12-30
KR930000505A (ko) 1993-01-15
NZ243337A (en) 1994-03-25
CA2072520A1 (en) 1992-12-28
IL102334A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
CA2036876A1 (fr) Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK0944617T3 (da) Krystaller af benzimidazolderivater og deres fremstilling
NO165145C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo-(4,5-c)-kinolin-4-aminderivater.
ES473074A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
NO922521L (no) Piperidinyletanolderivater med terapeutisk virkning
ATE139783T1 (de) Azasteroide zur behandlung prostatischer hypertrophie, ihre herstellung und verwendung
ES8203845A1 (es) Procedimiento para preparar derivados de piridoxina
HU9301155D0 (en) Methods for producing steroide derivatives and for their application in medical treatment
ES8700228A1 (es) Un procedimiento para producir derivados de propargiloxiacetonitrilo sustituido.
NO911158L (no) Hydantoinderivater.
FI882590A (fi) Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
IE872588L (en) Compounds
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
SE8305918L (sv) Mellanprodukter for framstellning av bensimidazolderivat
EP0139440A3 (en) Pyridinium compounds
NO175433C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive 1,8-benzonaftyridinderivater
DE69008473D1 (de) Dicyclohexylethylenderivate.
DK149058C (da) Analogifremgangsmaade til fremstilling af 4-(4,4-(diphenyl)butyl)-1-acylpiperaziner eller syreadditionssalte deraf
NO171362C (no) Analogifremgangsmaate for fremstilling av nye aralkylaminforbindelser og deres salter
NO922945L (no) Pyrazolderivater
ES8503681A1 (es) Procedimiento de preparacion de derivados del biciclo (4.2.0.) 1,3,5-octatrieno
NO934227L (no) Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO861244L (no) Fremgangsmaate ved fremstilling av nye therapeutisk aktive (4.2.01)-bicyclooctanderivater.
CA2007760A1 (fr) Nouveaux derives de benzonaphtyridine-1,8, leur preparation et les compositions qui les contiennent
ES473775A1 (es) Perfeccionamientos en o relacionados con compuestos organi- cos